At Sun Yat-sen University Cancer Center, 95 Chinese patients with NSCLC were treated with anti-PD-(L)1 monotherapies, with 73 patients being included in the final analysis with evaluable radiological results. The gene discussed is CD274; the disease is non-small cell lung carcinoma.